Hepatology
News
Trial results for hepatitis C antivirals not generalizable to coinfected HIV/HCV patients
Clinical trial results for direct-acting antivirals against hepatitis C virus (HCV) may have limited generalizability for patients coinfected with...
News
New population testing algorithm may improve hepatitis C surveillance
An algorithm that accurately estimates the population-level incidence of hepatitis C infection may boost public health efforts in high-risk...
News
Neurosurgeon memoir illuminates the journey through cancer treatment and acceptance of mortality
A neurosurgeon who had just completed his residency has left a memoir of his experiences as a physician, patient, and a dying man.
News
‘D-drugs’ linked to liver disease, cancer in HIV patients
The cumulative use of dideoxynucleoside analogues, or ‘d-drugs,’ in treatment of HIV-positive patients was independently associated with increased...
News
Nonalcoholic fatty liver disease will keep rising ‘in near term’
Nonalcoholic fatty liver disease (NAFLD) almost tripled among United States veterans in a recent 9-year period, investigators reported.
News
Nonalcoholic fatty liver disease linked to liver cancer without cirrhosis
About 13% of U.S. veterans with hepatocellular carcinoma had no evidence of preexisting cirrhosis, researchers reported in the January issue of...
News
Hepatitis C virus infection linked to cardiovascular death, disease, and stroke
Patients with hepatitis C virus infection face a significantly increased risk of cardiovascular death, subclinical carotid thickening and...
News
Hepatitis C linked to Parkinson’s disease
Hepatitis C infection may increase the risk of Parkinson’s disease, according to a nationwide population-based study from the Taiwan National...
News
New antivirals, more screening could slash hepatitis C cases
Hepatitis C could be reduced by 90% or more in the United States by the year 2040 with the use of direct-acting antivirals, near-universal...
News
ELF the most effective mortality predictor for coinfected HIV, HCV patients
A new study concluded that enhanced liver fibrosis (ELF) was significantly more effective than were APRI and FIB-4 at predicting all-cause...
Conference Coverage
Proportion of HCV patients in U.S. with cirrhosis climbing
Key clinical point: Despite a national decline in the prevalence of hepatitis C virus infection, the prevalence of cirrhosis among HCV-infected...